Literature DB >> 23918362

Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes.

Laure Ysebrant de Lendonck1, Sandrine Tonon, Muriel Nguyen, Patricia Vandevenne, Iain Welsby, Valerie Martinet, Céline Molle, Louis-Marie Charbonnier, Oberdan Leo, Stanislas Goriely.   

Abstract

IFN regulatory factor (IRF) 3 plays a key role in innate responses against viruses. Herein we assessed its contribution to T-cell activation. We observed that poly(I:C)-induced IRF3 activation in CD8 T cells represses IL-17 expression in a type I IFN-independent fashion. Even in the absence of poly(I:C), polyclonally activated naïve IRF3(-/-) CD8 T cells expressed high levels of IL-17 and IL-23R in comparison with wild-type cells. Furthermore, IRF3(-/-) OT1 cells adoptively transferred into wild-type hosts also produced higher IL-17 levels upon immunization than their wild-type counterparts. This phenotype could be reversed by ectopic expression of IRF3, confirming that this effect is intrinsic to T cells. We show that IRF3 directly interacts with RORγt in the cytoplasm through its IRF interaction domain and limits its ability to bind and transactivate the IL-17 promoter. These observations uncover an unexpected role of IRF3 in the control of CD8 T-cell polarization.

Entities:  

Keywords:  Tc17; Th17; cytokine; enhancer; transcription factor

Mesh:

Substances:

Year:  2013        PMID: 23918362      PMCID: PMC3752229          DOI: 10.1073/pnas.1219221110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.

Authors:  Anne Brüstle; Sylvia Heink; Magdalena Huber; Christine Rosenplänter; Christine Stadelmann; Philipp Yu; Enrico Arpaia; Tak W Mak; Thomas Kamradt; Michael Lohoff
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

Review 2.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

Review 3.  The IRF family transcription factors in immunity and oncogenesis.

Authors:  Tomohiko Tamura; Hideyuki Yanai; David Savitsky; Tadatsugu Taniguchi
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

4.  Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor.

Authors:  Julie Tabiasco; Estelle Devêvre; Nathalie Rufer; Bruno Salaun; Jean-Charles Cerottini; Daniel Speiser; Pedro Romero
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

5.  The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.

Authors:  Beichu Guo; Elmer Y Chang; Genhong Cheng
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

6.  Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat.

Authors:  Kenji Ichiyama; Hideyuki Yoshida; Yu Wakabayashi; Takatoshi Chinen; Kazuko Saeki; Mako Nakaya; Giichi Takaesu; Shohei Hori; Akihiko Yoshimura; Takashi Kobayashi
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

7.  Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4.

Authors:  Michael Lohoff; Hans-Willi Mittrücker; Stefan Prechtl; Susi Bischof; Frank Sommer; Sonja Kock; David A Ferrick; Gordon S Duncan; Andre Gessner; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

8.  Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch.

Authors:  Daniel Panne; Sarah M McWhirter; Tom Maniatis; Stephen C Harrison
Journal:  J Biol Chem       Date:  2007-05-25       Impact factor: 5.157

9.  The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells.

Authors:  Shin-ichi Kano; Kojiro Sato; Yasuyuki Morishita; Sabine Vollstedt; Sunhwa Kim; Keith Bishop; Kenya Honda; Masato Kubo; Tadatsugu Taniguchi
Journal:  Nat Immunol       Date:  2007-12-02       Impact factor: 25.606

10.  CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver.

Authors:  Ye Htun Oo; Vanessa Banz; Dean Kavanagh; Evaggelia Liaskou; David R Withers; Elizabeth Humphreys; Gary M Reynolds; Laura Lee-Turner; Neena Kalia; Stefan G Hubscher; Paul Klenerman; Bertus Eksteen; David H Adams
Journal:  J Hepatol       Date:  2012-07-14       Impact factor: 25.083

View more
  15 in total

1.  Significant role for IRF3 in both T cell and APC effector functions during T cell responses.

Authors:  Zacharey Guinn; Anna T Lampe; Deborah M Brown; Thomas M Petro
Journal:  Cell Immunol       Date:  2016-09-04       Impact factor: 4.868

2.  Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells.

Authors:  Zeguo Zhao; Maud Condomines; Sjoukje J C van der Stegen; Fabiana Perna; Christopher C Kloss; Gertrude Gunset; Jason Plotkin; Michel Sadelain
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

3.  Distinctive expression of interleukin-23 receptor subunits on human Th17 and γδ T cells.

Authors:  Bruce D Wines; May L Yap; Maree S Powell; Peck-Szee Tan; K Kerry Ko; Eva Orlowski; P Mark Hogarth
Journal:  Immunol Cell Biol       Date:  2016-09-20       Impact factor: 5.126

4.  IRF3 deficiency impacts granzyme B expression and maintenance of memory T cell function in response to viral infection.

Authors:  Tyler C Moore; Alexander J Vogel; Thomas M Petro; Deborah M Brown
Journal:  Microbes Infect       Date:  2015-03-13       Impact factor: 2.700

5.  IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR.

Authors:  Karolina Maciag; Raktima Raychowdhury; Karen Smith; Alexis M Schneider; Jörn Coers; Maxwell R Mumbach; Schraga Schwartz; Nir Hacohen
Journal:  J Leukoc Biol       Date:  2021-11-26       Impact factor: 6.011

Review 6.  Interferon regulatory factor 3 in adaptive immune responses.

Authors:  Laure Ysebrant de Lendonck; Valerie Martinet; Stanislas Goriely
Journal:  Cell Mol Life Sci       Date:  2014-05-31       Impact factor: 9.261

7.  DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.

Authors:  Petro Starokadomskyy; Terry Gemelli; Jonathan J Rios; Chao Xing; Richard C Wang; Haiying Li; Vladislav Pokatayev; Igor Dozmorov; Shaheen Khan; Naoteru Miyata; Guadalupe Fraile; Prithvi Raj; Zhe Xu; Zigang Xu; Lin Ma; Zhimiao Lin; Huijun Wang; Yong Yang; Dan Ben-Amitai; Naama Orenstein; Huda Mussaffi; Eulalia Baselga; Gianluca Tadini; Eyal Grunebaum; Adrijan Sarajlija; Konrad Krzewski; Edward K Wakeland; Nan Yan; Maria Teresa de la Morena; Andrew R Zinn; Ezra Burstein
Journal:  Nat Immunol       Date:  2016-03-28       Impact factor: 25.606

8.  Genetic Variation of Goat Interferon Regulatory Factor 3 Gene and Its Implication in Goat Evolution.

Authors:  Moses Okpeku; Ali Esmailizadeh; Adeniyi C Adeola; Liping Shu; Yesheng Zhang; Yangzi Wang; Timothy M Sanni; Ikhide G Imumorin; Sunday O Peters; Jiajin Zhang; Yang Dong; Wen Wang
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

9.  Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?

Authors:  Emmanuel Faure; Julien Poissy; Anne Goffard; Clement Fournier; Eric Kipnis; Marie Titecat; Perinne Bortolotti; Laura Martinez; Sylvain Dubucquoi; Rodrigue Dessein; Philippe Gosset; Daniel Mathieu; Benoit Guery
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

10.  Intrinsic MyD88-Akt1-mTOR Signaling Coordinates Disparate Tc17 and Tc1 Responses during Vaccine Immunity against Fungal Pneumonia.

Authors:  Som Gowda Nanjappa; Nydiaris Hernández-Santos; Kevin Galles; Marcel Wüthrich; M Suresh; Bruce S Klein
Journal:  PLoS Pathog       Date:  2015-09-14       Impact factor: 7.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.